Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series.

ABSTRACT:

Background

Acute respiratory distress syndrome is an important clinical presentation of respiratory complications caused by severe acute respiratory syndrome coronavirus 2, a novel coronavirus responsible for the ongoing pandemic. The disease is poorly understood, and immunopathogenesis is constantly evolving. Cytokine release syndrome remains central to pathology of coronavirus disease 2019. Antivirals, anticytokine treatment, and other pharmacological approaches have failed to treat it. CytoSorb, an extracorporeal cytokine adsorber that reduces the cytokine storm and other inflammatory mediators in the blood, seems promising in treating severely ill patients with coronavirus disease 2019.

Case presentation

This article presents three cases of Asian ethnicity of severely il

SUBMITTER: Mehta Y 

PROVIDER: S-EPMC8448661 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature